{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:52:27Z","timestamp":1791186747741,"version":"4.1.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00666-2","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:27:54Z","timestamp":1791178074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5903-691X","authenticated-orcid":false,"given":"Anurag","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0101-1064","authenticated-orcid":false,"given":"Pallvi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Rangra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-4787","authenticated-orcid":false,"given":"Kaunava Roy","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7585-7128","authenticated-orcid":false,"given":"Akshay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"9","key":"666_CR1","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/1061186X.2025.2509283","volume":"33","author":"N Ebadpour","year":"2025","unstructured":"Ebadpour N, Abavisani M, Sahebkar A. Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomics. J Drug Target. 2025;33(9):1495\u2013510.","journal-title":"J Drug Target"},{"issue":"8","key":"666_CR2","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533.","journal-title":"PLoS Biol"},{"issue":"10","key":"666_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/17425247.2023.2233900","volume":"20","author":"S Kamath","year":"2023","unstructured":"Kamath S, et al. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opin Drug Deliv. 2023;20(10):1315\u201331.","journal-title":"Expert Opin Drug Deliv"},{"issue":"37","key":"666_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.2174\/0113816128354250250326045943","volume":"31","author":"MS Jain","year":"2025","unstructured":"Jain MS, et al. Harnessing the human microbiome for innovative drug delivery systems: Exploring pharmacomicrobiomics and targeted therapies. Curr Pharm Design. 2025;31(37):2959\u201371.","journal-title":"Curr Pharm Design"},{"issue":"4","key":"666_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00203-025-04688-3","volume":"208","author":"N Kumar","year":"2026","unstructured":"Kumar N, et al. Modulating drug response through the gut microbiome: pathways to precision therapy. Arch Microbiol. 2026;208(4):163.","journal-title":"Arch Microbiol"},{"key":"666_CR6","doi-asserted-by":"crossref","unstructured":"Chenchula S, et al. Pharmacomicrobiomics\u2013Another frontier of precision medicine. Medknow. 2024;237\u201341.","DOI":"10.4103\/ijp.ijp_646_24"},{"issue":"3","key":"666_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/amh70030036","volume":"70","author":"ECN Lim","year":"2025","unstructured":"Lim ECN, Lim CED. Microbiome-Targeted Therapies in Gastrointestinal Diseases: Clinical Evidence and Emerging Innovations. Acta Microbiol Hellenica. 2025;70(3):36.","journal-title":"Acta Microbiol Hellenica"},{"issue":"6","key":"666_CR8","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/ajt.15753","volume":"20","author":"T Liwinski","year":"2020","unstructured":"Liwinski T, Elinav E. Harnessing the microbiota for therapeutic purposes. Am J Transplant. 2020;20(6):1482\u20138.","journal-title":"Am J Transplant"},{"issue":"5","key":"666_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/biomedicines14050969","volume":"14","author":"P Pinton","year":"2026","unstructured":"Pinton P. Microbiome-Based Therapies in Ulcerative Colitis: Mechanisms, Clinical Evidence, and a Precision-Medicine Framework. Biomedicines. 2026;14(5):969.","journal-title":"Biomedicines"},{"issue":"1","key":"666_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgh.16795","volume":"40","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. Gut microbiome-targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta\u2010analysis. J Gastroenterol Hepatol. 2025;40(1):78\u201388.","journal-title":"J Gastroenterol Hepatol"},{"key":"666_CR11","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.medidd.2022.100134","volume":"15","author":"A Sultana","year":"2022","unstructured":"Sultana A, et al. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Med Drug Discovery. 2022;15:100134.","journal-title":"Med Drug Discovery"},{"issue":"19","key":"666_CR12","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","volume":"26","author":"S Adepu","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.","journal-title":"Molecules"},{"issue":"4","key":"666_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","volume":"14","author":"SZ Alshawwa","year":"2022","unstructured":"Alshawwa SZ, et al. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022;14(4):883.","journal-title":"Pharmaceutics"},{"key":"666_CR14","doi-asserted-by":"publisher","unstructured":"Jain KK. An overview of drug delivery systems. In: Jain KK, editor. Drug Delivery Systems. Methods in Molecular Biology, vol. 2059. New York, NY: Springer; 2020. pp. 1\u201354 https:\/\/doi.org\/10.1007\/978-1-4939-9798-5_1","DOI":"10.1007\/978-1-4939-9798-5_1"},{"key":"666_CR15","doi-asserted-by":"publisher","first-page":"119912","DOI":"10.1016\/j.ijpharm.2020.119912","volume":"590","author":"F Laffleur","year":"2020","unstructured":"Laffleur F, Keckeis V. Advances in drug delivery systems: Work in progress still needed? Int J Pharm. 2020;590:119912.","journal-title":"Int J Pharm"},{"key":"666_CR16","doi-asserted-by":"crossref","unstructured":"Bagade O, Sampathi S. Restoration and sustenance of nano drug delivery systems: Potential, challenges, and limitations. In: Kulkarni S, Haghi AK, Manwatkar S, editors. Biosystems, Biomedical & Drug Delivery Systems: Characterization, Restoration and Optimization. Springer; 2024. p. 105\u2013139.","DOI":"10.1007\/978-981-97-2596-0_6"},{"issue":"1\u20133","key":"666_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clay.2006.06.015","volume":"36","author":"C Aguzzi","year":"2007","unstructured":"Aguzzi C, et al. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36(1\u20133):22\u201336.","journal-title":"Appl Clay Sci"},{"key":"666_CR18","doi-asserted-by":"crossref","unstructured":"Marwah H, et al. Strengths, limitations, and regulatory aspects of hybrid drug delivery systems, in Hybrid nanomaterials for drug delivery. Elsevier; 2022. pp. 339\u201355.","DOI":"10.1016\/B978-0-323-85754-3.00011-3"},{"issue":"6","key":"666_CR19","doi-asserted-by":"publisher","first-page":"e22350","DOI":"10.1096\/fj.202101986R","volume":"36","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, et al. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. FASEB J. 2022;36(6):e22350.","journal-title":"FASEB J"},{"issue":"2","key":"666_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4314\/ajcem.v21i2.1","volume":"21","author":"M Ojezele","year":"2020","unstructured":"Ojezele M. Microbiome: pharmacokinetics, pharmacodynamics and drug\/xenobiotic interactions. Afr J Clin Experimental Microbiol. 2020;21(2):78\u201387.","journal-title":"Afr J Clin Experimental Microbiol"},{"issue":"10","key":"666_CR21","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1172\/JCI72335","volume":"124","author":"RN Carmody","year":"2014","unstructured":"Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Investig. 2014;124(10):4173\u201381.","journal-title":"J Clin Investig"},{"key":"666_CR22","doi-asserted-by":"crossref","unstructured":"Pal R, et al. Microbiota\u2013Drug Interaction and Its Influence on Drug Metabolism and Toxicity, in Microbiota Profiling for Precision Medicine: Biomarker-Targeted Drug Delivery Strategies. Springer; 2025. pp. 59\u201395.","DOI":"10.1007\/978-981-95-2104-3_3"},{"issue":"11","key":"666_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1124\/dmd.117.077024","volume":"45","author":"CY Li","year":"2017","unstructured":"Li CY, et al. Novel interactions between gut microbiome and host drug-processing genes modify the hepatic metabolism of the environmental chemicals polybrominated diphenyl ethers. Drug Metab Dispos. 2017;45(11):1197\u2013214.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"666_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17425255.2026.2631415","volume":"22","author":"A Belan\u010di\u0107","year":"2026","unstructured":"Belan\u010di\u0107 A, et al. Microbiome-driven PKs: redefining drug metabolism beyond host enzymes. Expert Opin Drug Metab Toxicol. 2026;22(1):9\u201328.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1\u20132","key":"666_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/03602532.2023.2186313","volume":"55","author":"A D\u017eidi\u0107-Krivi\u0107","year":"2023","unstructured":"D\u017eidi\u0107-Krivi\u0107 A, et al. Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metab Rev. 2023;55(1\u20132):126\u201339.","journal-title":"Drug Metab Rev"},{"issue":"8","key":"666_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40262-021-01032-y","volume":"60","author":"SM Tsunoda","year":"2021","unstructured":"Tsunoda SM, et al. Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability. Clin Pharmacokinet. 2021;60(8):971.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"666_CR27","first-page":"26","volume":"12","author":"RS Maddu","year":"2025","unstructured":"Maddu RS, Ghanta AS, Babu PV. Microbiome-Drug Interactions: A Critical Review of Pharmacokinetic and Pharmacodynamic Modulation. Trop J Pharm Life Sci. 2025;12(3):26\u201341.","journal-title":"Trop J Pharm Life Sci"},{"key":"666_CR28","doi-asserted-by":"publisher","first-page":"130145","DOI":"10.1016\/j.ijbiomac.2024.130145","volume":"264","author":"L-j Xia","year":"2024","unstructured":"Xia L-j, et al. Targeted inhibition of gut bacterial \u03b2-glucuronidases by octyl gallate alleviates mycophenolate mofetil-induced gastrointestinal toxicity. Int J Biol Macromol. 2024;264:130145.","journal-title":"Int J Biol Macromol"},{"issue":"6445","key":"666_CR29","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal V, et al. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364(6445):eaau6323.","journal-title":"Science"},{"issue":"6143","key":"666_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser HJ, et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science. 2013;341(6143):295\u20138.","journal-title":"Science"},{"issue":"3","key":"666_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","volume":"29","author":"RS Mehta","year":"2023","unstructured":"Mehta RS, et al. Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nat Med. 2023;29(3):700\u20139.","journal-title":"Nat Med"},{"issue":"7","key":"666_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850\u20138.","journal-title":"Nat Med"},{"issue":"3","key":"666_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1124\/dmd.118.084772","volume":"47","author":"Y Guo","year":"2019","unstructured":"Guo Y, et al. Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites. Drug Metab Dispos. 2019;47(3):194\u2013202.","journal-title":"Drug Metab Dispos"},{"issue":"7762","key":"666_CR34","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M, et al. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462\u20137.","journal-title":"Nature"},{"issue":"6","key":"666_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat reviews Gastroenterol Hepatol. 2017;14(6):356\u201365.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"7698","key":"666_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623\u20138.","journal-title":"Nature"},{"key":"666_CR37","doi-asserted-by":"publisher","unstructured":"Ma Y, Liu X, Wang J. Small molecules in the big picture of gut microbiome-host cross-talk. EBioMedicine. 2022;81:104085. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104085","DOI":"10.1016\/j.ebiom.2022.104085"},{"issue":"3","key":"666_CR38","doi-asserted-by":"publisher","first-page":"MSB202010116","DOI":"10.15252\/msb.202010116","volume":"17","author":"M Zimmermann","year":"2021","unstructured":"Zimmermann M, et al. Towards a mechanistic understanding of reciprocal drug\u2013microbiome interactions. Mol Syst Biol. 2021;17(3):MSB202010116.","journal-title":"Mol Syst Biol"},{"issue":"8","key":"666_CR39","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1161\/CIRCRESAHA.123.321763","volume":"132","author":"G Glorieux","year":"2023","unstructured":"Glorieux G, et al. Role of the microbiome in gut-heart-kidney cross talk. Circul Res. 2023;132(8):1064\u201383.","journal-title":"Circul Res"},{"issue":"2","key":"666_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cmet.2025.12.017","volume":"38","author":"N Ding","year":"2026","unstructured":"Ding N, et al. Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis. Cell Metabol. 2026;38(2):370\u201387. e10.","journal-title":"Cell Metabol"},{"issue":"7","key":"666_CR41","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/biomedicines13071761","volume":"13","author":"A Nowicka","year":"2025","unstructured":"Nowicka A, et al. Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML\u2014One Step Closer to Personalized Medicine. Biomedicines. 2025;13(7):1761.","journal-title":"Biomedicines"},{"key":"666_CR42","doi-asserted-by":"crossref","unstructured":"Huang W et al. The signatures and crosstalk of gut mycobiome, microbiome, and metabolites in drug-induced liver injury. Mycology. 2026;2633942.","DOI":"10.1080\/21501203.2026.2633942"},{"issue":"2","key":"666_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/microorganisms14020471","volume":"14","author":"J Zhou","year":"2026","unstructured":"Zhou J, et al. The Gut\u2013Liver Axis in MASLD: From Host\u2013Microbiome Crosstalk to Precision Therapeutics. Microorganisms. 2026;14(2):471.","journal-title":"Microorganisms"},{"issue":"2","key":"666_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/onco6020021","volume":"6","author":"R Dilawari","year":"2026","unstructured":"Dilawari R, et al. Microbiome-Driven Diagnostic and Therapeutic Strategies in Cancer. Onco. 2026;6(2):21.","journal-title":"Onco"},{"issue":"2","key":"666_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/cimb48020165","volume":"48","author":"DG Nair","year":"2026","unstructured":"Nair DG, Nair DB, Weiskirchen R. Reconstructing Liver Fibrosis: 3D Human Models, Microbiome Interfaces, and Therapeutic Innovation. Curr Issues Mol Biol. 2026;48(2):165.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"666_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/genes14010055","volume":"14","author":"G Conti","year":"2022","unstructured":"Conti G, et al. Pharmacomicrobiomics in anticancer therapies: why the gut microbiota should be pointed out. Genes. 2022;14(1):55.","journal-title":"Genes"},{"key":"666_CR47","doi-asserted-by":"crossref","unstructured":"Purhematy A, Sharififar F, Halilu EM. Computational insights into plant-derived compounds modulating the microbiota\u2013gut\u2013brain axis in neuroinflammatory diseases. Adv Gut Microbiome Res. 2026;2026(1):4722684.","DOI":"10.1155\/agm3\/4722684"},{"key":"666_CR48","doi-asserted-by":"crossref","unstructured":"Preetam S, et al. Role of gut microbiota in cancer modulation: molecular mechanisms and emerging therapeutic strategies. Infect Agents Cancer. 2026.","DOI":"10.1186\/s13027-026-00767-2"},{"key":"666_CR49","doi-asserted-by":"publisher","first-page":"1710733","DOI":"10.3389\/fimmu.2025.1710733","volume":"16","author":"G Li","year":"2025","unstructured":"Li G, et al. Gut microbiota-derived metabolites modulate Treg\/Th17 balance: novel therapeutic targets in autoimmune diseases. Front Immunol. 2025;16:1710733.","journal-title":"Front Immunol"},{"key":"666_CR50","unstructured":"Patil A et al. Nano-and micro-particle drug delivery systems for enhancing the bioavailability of anti-diabetic agents. J Neonatal Surg. 2025;14(32s)."},{"issue":"4","key":"666_CR51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1021\/acs.bioconjchem.5c00037","volume":"36","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, et al. Fc Multisite Conjugation and Prolonged Delivery of the Folate-Targeted Drug Conjugate EC140. Bioconjug Chem. 2025;36(4):762\u20139.","journal-title":"Bioconjug Chem"},{"issue":"9","key":"666_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13205-024-04051-1","volume":"14","author":"S Singh","year":"2024","unstructured":"Singh S, et al. Application of nano-and micro-particle-based approaches for selected bronchodilators in management of asthma. 3 Biotech. 2024;14(9):208.","journal-title":"3 Biotech"},{"key":"666_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpc.2016.03.006","volume":"213","author":"JH Yoon","year":"2016","unstructured":"Yoon JH, et al. Multi-ligand functionalized particle design for cell targeting and drug delivery. Biophys Chem. 2016;213:25\u201331.","journal-title":"Biophys Chem"},{"issue":"1","key":"666_CR54","doi-asserted-by":"publisher","first-page":"16437","DOI":"10.1038\/s41598-024-66634-5","volume":"14","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, et al. Rifabutin loaded inhalable \u03b2-glucan microparticle based drug delivery system for pulmonary TB. Sci Rep. 2024;14(1):16437.","journal-title":"Sci Rep"},{"issue":"2","key":"666_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1208\/s12249-026-03348-z","volume":"27","author":"K Bansal","year":"2026","unstructured":"Bansal K, Mukharya A, Jindal AB. Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems. AAPS PharmSciTech. 2026;27(2):92.","journal-title":"AAPS PharmSciTech"},{"key":"666_CR56","doi-asserted-by":"publisher","first-page":"141567","DOI":"10.1016\/j.ijbiomac.2025.141567","volume":"306","author":"Y Geng","year":"2025","unstructured":"Geng Y, et al. Preparation of pH-enzyme dual-responsive gel microspheres and their treatment of ulcerative colitis. Int J Biol Macromol. 2025;306:141567.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"666_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/17435390.2025.2484002","volume":"19","author":"M Sadighi Shamami","year":"2025","unstructured":"Sadighi Shamami M, et al. The current advancements in chitosan nanoparticles in the management of non-surgical periodontitis treatment. Nanotoxicology. 2025;19(3):290\u2013324.","journal-title":"Nanotoxicology"},{"key":"666_CR58","doi-asserted-by":"crossref","unstructured":"Carolak E, et al. Genetically engineered probiotic E. coli Nissle 1917 enhances protection against Salmonella via increased adhesion and systemic T-cell responses. npj Biofilms and Microbiomes. 2026.","DOI":"10.1038\/s41522-026-01011-w"},{"issue":"2","key":"666_CR59","doi-asserted-by":"publisher","first-page":"dmm052620","DOI":"10.1242\/dmm.052620","volume":"19","author":"R Palou","year":"2026","unstructured":"Palou R, et al. A yeast synthetic biotic platform for delivery of therapeutic nanobodies to ameliorate gastrointestinal inflammation. Dis Models Mech. 2026;19(2):dmm052620.","journal-title":"Dis Models Mech"},{"issue":"2","key":"666_CR60","first-page":"13","volume":"1","author":"BS Sekhon","year":"2010","unstructured":"Sekhon BS, Jairath S. Prebiotics, probiotics and synbiotics: an overview. J Pharm Educ Res. 2010;1(2):13\u201336.","journal-title":"J Pharm Educ Res"},{"issue":"1","key":"666_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/00439339.2022.1988804","volume":"78","author":"R Khomayezi","year":"2022","unstructured":"Khomayezi R, Adewole D. Probiotics, prebiotics, and synbiotics: an overview of their delivery routes and effects on growth and health of broiler chickens. World\u2019s Poult Sci J. 2022;78(1):57\u201381.","journal-title":"World\u2019s Poult Sci J"},{"issue":"9","key":"666_CR62","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1021\/acsabm.5c00959","volume":"8","author":"D Sahoo","year":"2025","unstructured":"Sahoo D, et al. Probiotic bacteria as therapeutics and biohybrid drug carriers: Advances, design Strategies, and future outlook. ACS Appl Bio Mater. 2025;8(9):7513\u201334.","journal-title":"ACS Appl Bio Mater"},{"key":"666_CR63","doi-asserted-by":"crossref","unstructured":"Kumar G, et al. Synbiotics in oral drug delivery, in synbiotics in human health: biology to drug delivery. Springer; 2024. pp. 413\u201333.","DOI":"10.1007\/978-981-99-5575-6_20"},{"issue":"9","key":"666_CR64","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1080\/10408398.2020.1854169","volume":"62","author":"A Rashidinejad","year":"2022","unstructured":"Rashidinejad A, et al. Co-encapsulation of probiotics with prebiotics and their application in functional\/synbiotic dairy products. Crit Rev Food Sci Nutr. 2022;62(9):2470\u201394.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"666_CR65","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, et al. Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnol. 2024;22(1):365.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"666_CR66","doi-asserted-by":"publisher","first-page":"44929","DOI":"10.1038\/srep44929","volume":"7","author":"JY Park","year":"2017","unstructured":"Park JY, et al. Genetic engineering of a temperate phage-based delivery system for CRISPR\/Cas9 antimicrobials against Staphylococcus aureus. Sci Rep. 2017;7(1):44929.","journal-title":"Sci Rep"},{"issue":"2","key":"666_CR67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/pharmaceutics18020185","volume":"18","author":"A Elbehiry","year":"2026","unstructured":"Elbehiry A, Marzouk E, Abalkhail A. Nano-enabled delivery of phage-based antibacterials against ESKAPE pathogens. Pharmaceutics. 2026;18(2):185.","journal-title":"Pharmaceutics"},{"issue":"7","key":"666_CR68","doi-asserted-by":"publisher","first-page":"2307111","DOI":"10.1002\/smll.202307111","volume":"20","author":"XT Li","year":"2024","unstructured":"Li XT, et al. Recent Progress in Phage-Based Nanoplatforms for Tumor Therapy. Small. 2024;20(7):2307111.","journal-title":"Small"},{"issue":"6","key":"666_CR69","doi-asserted-by":"publisher","first-page":"pgaf176","DOI":"10.1093\/pnasnexus\/pgaf176","volume":"4","author":"K Kiga","year":"2025","unstructured":"Kiga K, et al. Development of a nonreplicative phage-based DNA delivery system and its application to antimicrobial therapies. PNAS nexus. 2025;4(6):pgaf176.","journal-title":"PNAS nexus"},{"issue":"42","key":"666_CR70","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1039\/D3TB01805A","volume":"11","author":"S Fooladi","year":"2023","unstructured":"Fooladi S, Rabiee N, Iravani S. Genetically engineered bacteria: a new frontier in targeted drug delivery. J Mater Chem B. 2023;11(42):10072\u201387.","journal-title":"J Mater Chem B"},{"issue":"11","key":"666_CR71","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/1389201024666221220113517","volume":"24","author":"PL Patil","year":"2023","unstructured":"Patil PL, et al. Engineered bacteria: general overview as therapeutic agent and a novel drug delivery system. Curr Pharm Biotechnol. 2023;24(11):1351\u201364.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"666_CR72","first-page":"6638269","volume":"2024","author":"M Mahdizade Ari","year":"2024","unstructured":"Mahdizade Ari M, et al. Genetically engineered microorganisms and their impact on human health. Int J Clin Pract. 2024;2024(1):6638269.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"666_CR73","first-page":"1458","volume":"72","author":"Z Zahedifard","year":"2025","unstructured":"Zahedifard Z, Mahmoodi S, Ghasemian A. Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review. Biotechnol Appl Chem. 2025;72(5):1458\u201376.","journal-title":"Biotechnol Appl Chem"},{"issue":"48","key":"666_CR74","doi-asserted-by":"publisher","first-page":"2302702","DOI":"10.1002\/smll.202302702","volume":"19","author":"P Guo","year":"2023","unstructured":"Guo P, et al. Advancement of engineered bacteria for orally delivered therapeutics. Small. 2023;19(48):2302702.","journal-title":"Small"},{"issue":"9","key":"666_CR75","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella VM, et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol. 2018;36(9):857\u201364.","journal-title":"Nat Biotechnol"},{"issue":"475","key":"666_CR76","doi-asserted-by":"publisher","first-page":"eaau7975","DOI":"10.1126\/scitranslmed.aau7975","volume":"11","author":"CB Kurtz","year":"2019","unstructured":"Kurtz CB, et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 2019;11(475):eaau7975.","journal-title":"Sci Transl Med"},{"issue":"7","key":"666_CR77","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.31557\/APJCP.2020.21.7.1851","volume":"21","author":"GS Ana","year":"2020","unstructured":"Ana GS, et al. Topical treatment of oral mucositis in cancer patients: a systematic review of randomized clinical trials. Asian Pac J cancer prevention: APJCP. 2020;21(7):1851.","journal-title":"Asian Pac J cancer prevention: APJCP"},{"issue":"19","key":"666_CR78","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1080\/10408398.2024.2369946","volume":"65","author":"L Wang","year":"2025","unstructured":"Wang L, et al. Current research progress, opportunities, and challenges of Limosillactobacillus reuteri-based probiotic dietary strategies. Crit Rev Food Sci Nutr. 2025;65(19):3607\u201327.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"666_CR79","doi-asserted-by":"publisher","first-page":"2337312","DOI":"10.1080\/19490976.2024.2337312","volume":"16","author":"T Bratkovi\u010d","year":"2024","unstructured":"Bratkovi\u010d T, et al. New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation. Gut Microbes. 2024;16(1):2337312.","journal-title":"Gut Microbes"},{"issue":"12","key":"666_CR80","doi-asserted-by":"publisher","first-page":"e01593","DOI":"10.1002\/smtd.202501593","volume":"9","author":"Z Yu","year":"2025","unstructured":"Yu Z, et al. Engineered Bacterial Therapeutics: Controlled Release Approaches in Oncology. Small Methods. 2025;9(12):e01593.","journal-title":"Small Methods"},{"issue":"1","key":"666_CR81","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.30574\/ijsra.2023.8.1.0189","volume":"8","author":"H Ali","year":"2023","unstructured":"Ali H. Artificial intelligence in multi-omics data integration: Advancing precision medicine, biomarker discovery and genomic-driven disease interventions. Int J Sci Res Arch. 2023;8(1):1012\u201330.","journal-title":"Int J Sci Res Arch"},{"issue":"12","key":"666_CR82","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/biomedicines12122750","volume":"12","author":"G Molla","year":"2024","unstructured":"Molla G, Bitew M. Revolutionizing personalized medicine: synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines. 2024;12(12):2750.","journal-title":"Biomedicines"},{"key":"666_CR83","doi-asserted-by":"crossref","unstructured":"Thakur A. Strategies for biomarker identification and validation in precision medicine: microbial predictors, data integration, machine learning, and clinical trial insights, in microbiota profiling for precision medicine: biomarker-targeted drug delivery strategies. Springer; 2025. pp. 281\u2013307.","DOI":"10.1007\/978-981-95-2104-3_9"},{"issue":"7","key":"666_CR84","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/1354750X.2025.2591717","volume":"30","author":"A Yasmin","year":"2025","unstructured":"Yasmin A, et al. Emerging biomarkers in breast cancer: translational and multi-omics perspectives in precision oncology. Biomarkers. 2025;30(7):516\u201340.","journal-title":"Biomarkers"},{"key":"666_CR85","first-page":"281","volume-title":"Microbial Predictors, Data Integration, Machine Learning, and Clinical Trial","author":"A Thakur","year":"2025","unstructured":"Thakur A. Microbial Predictors, Data Integration, Machine Learning, and Clinical Trial. Microbiota Profiling for Precision Medicine: Biomarker-Targeted Drug Delivery Strategies; 2025. p. 281."},{"key":"666_CR86","doi-asserted-by":"publisher","unstructured":"Dwivedi J, Shukla MM, Upadhyay A, Wal A, Sharma KK, Gasmi A. From 16S rRNA to deep learning: Evolution of computational approaches in human microbiome studies. Comput Biol Chem. 2026;121:108852. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.10885210","DOI":"10.1016\/j.compbiolchem.2025.10885210"},{"issue":"27","key":"666_CR87","doi-asserted-by":"publisher","first-page":"109105","DOI":"10.3748\/wjg.v31.i27.109105","volume":"31","author":"A Khurana","year":"2025","unstructured":"Khurana A, Hartmann P. Gut microbiome-specific nanoparticle-based therapeutics for liver diseases. World J Gastroenterol. 2025;31(27):109105.","journal-title":"World J Gastroenterol"},{"key":"666_CR88","doi-asserted-by":"crossref","unstructured":"You C, Zhao X. From microbes to medicines: strategy, carrier design, and the hard problem of targeted delivery. Mol Microbiol Res. 2025;15.","DOI":"10.5376\/mmr.2025.15.0010"},{"key":"666_CR89","unstructured":"Utkina I. Developing microbiome-targeted therapeutics through community-based metabolic modelling. University of Toronto (Canada); 2025."},{"issue":"1","key":"666_CR90","doi-asserted-by":"publisher","first-page":"2644677","DOI":"10.1080\/19490976.2026.2644677","volume":"18","author":"Z Li","year":"2026","unstructured":"Li Z, et al. Gut microbiome and metabolic health: mechanisms and precision interventions. Gut Microbes. 2026;18(1):2644677.","journal-title":"Gut Microbes"},{"key":"666_CR91","unstructured":"Shi X. Defining the causal contribution of the gut microbiota to cardiomyopathy pathogenesis as a basis for developing microbiome-targeted therapies. 2025."},{"key":"666_CR92","doi-asserted-by":"publisher","first-page":"104514","DOI":"10.1016\/j.tifs.2024.104514","volume":"148","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Food intervention strategy for oral microbiome: A review. Trends Food Sci Technol. 2024;148:104514.","journal-title":"Trends Food Sci Technol"},{"issue":"9","key":"666_CR93","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.3390\/ijms24098274","volume":"24","author":"JS Bruno","year":"2023","unstructured":"Bruno JS, et al. From pathogenesis to intervention: the importance of the microbiome in oral mucositis. Int J Mol Sci. 2023;24(9):8274.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"666_CR94","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3390\/microorganisms12091797","volume":"12","author":"JJ Rajasekaran","year":"2024","unstructured":"Rajasekaran JJ, et al. Oral microbiome: a review of its impact on oral and systemic health. Microorganisms. 2024;12(9):1797.","journal-title":"Microorganisms"},{"issue":"6","key":"666_CR95","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ijmm.2025.5651","volume":"56","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, et al. The gut-skin axis: Emerging insights in understanding and treating skin diseases through gut microbiome modulation. Int J Mol Med. 2025;56(6):210.","journal-title":"Int J Mol Med"},{"issue":"22","key":"666_CR96","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.3390\/molecules30224363","volume":"30","author":"K Wojciechowska","year":"2025","unstructured":"Wojciechowska K, Dos Santos K, Szewczyk. The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications. Molecules. 2025;30(22):4363.","journal-title":"Molecules"},{"issue":"4","key":"666_CR97","doi-asserted-by":"publisher","first-page":"e70352","DOI":"10.1111\/srt.70352","volume":"32","author":"R Tal\u00e9ns-Visconti","year":"2026","unstructured":"Tal\u00e9ns-Visconti R, Diez\u2010Sales O, N\u00e1cher A. Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions. Skin Res Technol. 2026;32(4):e70352.","journal-title":"Skin Res Technol"},{"issue":"4","key":"666_CR98","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.chom.2026.03.015","volume":"34","author":"J Dillen","year":"2026","unstructured":"Dillen J, et al. The female urogenital microbiome: ecological insights, therapeutic strategies, and molecular mechanisms. Cell Host Microbe. 2026;34(4):567\u201387.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"666_CR99","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/febs.17235","volume":"292","author":"KF Al","year":"2025","unstructured":"Al KF, et al. Interconnected microbiomes\u2014insights and innovations in female urogenital health. FEBS J. 2025;292(6):1378\u201396.","journal-title":"FEBS J"},{"issue":"1","key":"666_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/LGT.0000000000000645","volume":"26","author":"F De Seta","year":"2022","unstructured":"De Seta F, et al. The vaginal microbiome: III. The vaginal microbiome in various urogenital disorders. J Lower Genit Tract Dis. 2022;26(1):85\u201392.","journal-title":"J Lower Genit Tract Dis"},{"issue":"1","key":"666_CR101","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12915-021-01204-z","volume":"19","author":"KM Andralojc","year":"2021","unstructured":"Andralojc KM, et al. Novel high-resolution targeted sequencing of the cervicovaginal microbiome. BMC Biol. 2021;19(1):267.","journal-title":"BMC Biol"},{"key":"666_CR102","doi-asserted-by":"crossref","unstructured":"Saleh K, Guigon P. Coating and encapsulation processes in powder technology, in Handbook of powder technology. Elsevier; 2007. pp. 323\u201375.","DOI":"10.1016\/S0167-3785(07)80042-X"},{"key":"666_CR103","doi-asserted-by":"crossref","unstructured":"Mittal V. Encapsulation nanotechnologies. Wiley; 2013.","DOI":"10.1002\/9781118729175"},{"issue":"1","key":"666_CR104","doi-asserted-by":"publisher","first-page":"7367634","DOI":"10.1155\/ijfo\/7367634","volume":"2026","author":"S Islam","year":"2026","unstructured":"Islam S, et al. Encapsulation in Food Systems: From Technique-Driven Approaches to Functional, Scalable, and Sustainable Industrial Applications. Int J Food Sci. 2026;2026(1):7367634.","journal-title":"Int J Food Sci"},{"issue":"18","key":"666_CR105","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.3390\/app12189020","volume":"12","author":"A Balla","year":"2022","unstructured":"Balla A, et al. Recent advances in encapsulation techniques of plant growth-promoting microorganisms and their prospects in the sustainable agriculture. Appl Sci. 2022;12(18):9020.","journal-title":"Appl Sci"},{"issue":"1","key":"666_CR106","first-page":"e1664","volume":"13","author":"N Devnarain","year":"2021","unstructured":"Devnarain N, et al. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents\u2014An in\u2010depth review of the last two decades. Wiley interdisciplinary reviews: Nanomed Nanobiotechnol. 2021;13(1):e1664.","journal-title":"Wiley interdisciplinary reviews: Nanomed Nanobiotechnol"},{"issue":"10","key":"666_CR107","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/gels9100838","volume":"9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu BM. Current advances in stimuli-responsive hydrogels as smart drug delivery carriers. Gels. 2023;9(10):838.","journal-title":"Gels"},{"key":"666_CR108","doi-asserted-by":"crossref","unstructured":"Onzi G, et al. Stimuli-responsive nanocarriers for drug delivery, in The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics. Springer; 2022. pp. 1095\u2013107.","DOI":"10.1007\/978-3-030-84860-6_177"},{"issue":"13","key":"666_CR109","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.3390\/ijms21134724","volume":"21","author":"S Municoy","year":"2020","unstructured":"Municoy S, et al. Stimuli-responsive materials for tissue engineering and drug delivery. Int J Mol Sci. 2020;21(13):4724.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"666_CR110","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1021\/acs.biomac.5c01176","volume":"26","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, et al. Azo-Linked 5-ASA Hydrogel Microparticles with Enzyme Shielding for Sustained Drug Release in Ulcerative Colitis Therapy. Biomacromolecules. 2025;26(11):7656\u201369.","journal-title":"Biomacromolecules"},{"issue":"15","key":"666_CR111","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2174\/1381612023394485","volume":"8","author":"Md Graaf","year":"2002","unstructured":"Graaf Md, et al. Beta-glucuronidase-mediated drug release. Curr Pharm Design. 2002;8(15):1391\u2013403.","journal-title":"Curr Pharm Design"},{"issue":"3","key":"666_CR112","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/fbe2.70024","volume":"4","author":"J Renukadevi","year":"2025","unstructured":"Renukadevi J, et al. Gut-targeted nutraceutical delivery: engineering microbiome\u2010responsive nutraceutical interfaces. Food Bioeng. 2025;4(3):248\u201361.","journal-title":"Food Bioeng"},{"key":"666_CR113","first-page":"393","volume-title":"Reduction-Responsive Disulfide\u2010Containing Polymers for Biomedical Applications","author":"X Wang","year":"2021","unstructured":"Wang X, Wu D. Reduction-Responsive Disulfide\u2010Containing Polymers for Biomedical Applications. Sulfur\u2010Containing Polymers: From Synthesis to Functional Materials; 2021. pp. 393\u2013428."},{"issue":"3","key":"666_CR114","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/pharmaceutics18030284","volume":"18","author":"R Vadlapatla","year":"2026","unstructured":"Vadlapatla R, et al. Microbiome-Responsive Hydrogels: From Biological Cues to Smart Biomaterials. Pharmaceutics. 2026;18(3):284.","journal-title":"Pharmaceutics"},{"issue":"1","key":"666_CR115","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12951-025-03712-4","volume":"23","author":"H Singh","year":"2025","unstructured":"Singh H, et al. Smart hybrid nanomaterials for chronic infections: microbiome-responsive and sustainable therapeutic platforms. J Nanobiotechnol. 2025;23(1):698.","journal-title":"J Nanobiotechnol"},{"key":"666_CR116","doi-asserted-by":"crossref","unstructured":"Ghaemi M, et al. The MOF\u2013microbiome axis: a new paradigm for precision nanomedicine. Probiotics Antimicrob Proteins. 2026;1\u201318.","DOI":"10.1007\/s12602-025-10906-7"},{"issue":"7","key":"666_CR117","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/gutjnl-2025-33594610","volume":"75","author":"T Zhou","year":"2026","unstructured":"Zhou T, Zhao F. AI-empowered human microbiome research. Gut. 2026;75(7):1432\u201346. https:\/\/doi.org\/10.1136\/gutjnl-2025-33594610","journal-title":"Gut"},{"key":"666_CR118","doi-asserted-by":"crossref","unstructured":"Malakar S, et al. Understanding gut microbiome-based machine learning platforms: A review on therapeutic approaches using deep learning. Chem Biol Drug Des. 2024;103(3):e14505.","DOI":"10.1111\/cbdd.14505"},{"issue":"4","key":"666_CR119","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1556\/030.2025.02725","volume":"72","author":"R Kumar","year":"2025","unstructured":"Kumar R, et al. Artificial intelligence in gut microbiome research: Toward predictive diagnostics for neurodegenerative disorders. Acta Microbiol Immunol Hung. 2025;72(4):296\u2013312.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"19","key":"666_CR120","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.3390\/app14198627","volume":"14","author":"F D\u2019Urso","year":"2024","unstructured":"D\u2019Urso F, Broccolo F. Applications of artificial intelligence in microbiome analysis and probiotic interventions\u2014an overview and perspective based on the current state of the art. Appl Sci. 2024;14(19):8627.","journal-title":"Appl Sci"},{"issue":"2","key":"666_CR121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.20517\/mrr.2023.80","volume":"3","author":"P Manrique","year":"2024","unstructured":"Manrique P, et al. Past, present, and future of microbiome-based therapies. Microbiome Res Rep. 2024;3(2):23.","journal-title":"Microbiome Res Rep"},{"key":"666_CR122","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2020.06.036","volume":"113","author":"F Mehryab","year":"2020","unstructured":"Mehryab F, et al. Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges. Acta Biomater. 2020;113:42\u201362.","journal-title":"Acta Biomater"},{"key":"666_CR123","doi-asserted-by":"crossref","unstructured":"Pathak A, Singh SP. Next-Generation drug delivery systems. Springer; 2025.","DOI":"10.1007\/978-1-0716-4554-3"},{"key":"666_CR124","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/IJN.S236927","volume":"15","author":"U Ruman","year":"2020","unstructured":"Ruman U, Fakurazi S, Masarudin MJ, Hussein MZ. Nanocarrier-based therapeutics and theranostics drug delivery systems for next generation of liver cancer nanodrug modalities. Int J Nanomed. 2020;15:1437\u201356. https:\/\/doi.org\/10.2147\/IJN.S236927","journal-title":"Int J Nanomed"},{"issue":"7","key":"666_CR125","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748\u2013759.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"666_CR126","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/gels10040216","volume":"10","author":"MM Rana","year":"2024","unstructured":"Rana MM. De la Hoz Siegler, Evolution of hybrid hydrogels: Next-generation biomaterials for drug delivery and tissue engineering. Gels. 2024;10(4):216.","journal-title":"Gels"},{"key":"666_CR127","doi-asserted-by":"publisher","unstructured":"Misra A, Sharma S. Exploring clinical applications: precision medicine in gastrointestinal disorders, microbiota-driven cancer therapies and innovative interventions for neurological disorders\u2014insights from case studies. In: Singh SK, Vamanu E, Rai SN, Singh AK, editors. Microbiota Profiling for Precision Medicine: Biomarker-Targeted Drug Delivery Strategies. Singapore: Springer; 2025. p. 345\u2013383. https:\/\/doi.org\/10.1007\/978-981-95-2104-3_11.10","DOI":"10.1007\/978-981-95-2104-3_11.10"},{"issue":"4","key":"666_CR128","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1021\/acsptsci.4c00008","volume":"7","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, et al. Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies. ACS Pharmacol translational Sci. 2024;7(4):967\u201390.","journal-title":"ACS Pharmacol translational Sci"},{"issue":"3","key":"666_CR129","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/011568009633827324122406102110","volume":"26","author":"S Srivastava","year":"2026","unstructured":"Srivastava S, Anand A, Kandhula AG, Jaiswal P, Kumar S, Gulati M, Sachdeva M, Behl T. Precision medicine in colorectal cancer: targeted therapies and biomarker insights. Curr Cancer Drug Targets. 2026;26(3):349\u201366. https:\/\/doi.org\/10.2174\/011568009633827324122406102110","journal-title":"Curr Cancer Drug Targets"},{"key":"666_CR130","doi-asserted-by":"crossref","unstructured":"Prakash S, Bisht S, Jaiswal V. Microbiota-driven precision therapies: applications in autoimmune disorders, optimizing cancer therapy and advancements in gastrointestinal disease treatment. In: Singh SK, Vamanu E, Rai SN, Singh AK, editors. Microbiota Profiling for Precision Medicine: Biomarker-Targeted Drug Delivery Strategies. Singapore: Springer; 2025. p. 309\u2013343.","DOI":"10.1007\/978-981-95-2104-3_10"},{"key":"666_CR131","doi-asserted-by":"crossref","unstructured":"Yang M, Liu S, Zhang C. The related metabolic diseases and treatments of obesity. in Healthcare. MDPI; 2022.","DOI":"10.3390\/healthcare10091616"},{"issue":"1","key":"666_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127(1):1\u20134.","journal-title":"J Clin Investig"},{"issue":"2","key":"666_CR133","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.pop.2009.01.006","volume":"36","author":"RJ Koopman","year":"2009","unstructured":"Koopman RJ, et al. Obesity and metabolic disease. Prim Care: Clin Office Pract. 2009;36(2):257\u201370.","journal-title":"Prim Care: Clin Office Pract"},{"issue":"2","key":"666_CR134","doi-asserted-by":"publisher","first-page":"E143","DOI":"10.1152\/ajpendo.00304.2023","volume":"330","author":"X Zhang","year":"2026","unstructured":"Zhang X, et al. The role of orosomucoid in glucose and lipid metabolism and metabolic diseases. Am J Physiology-Endocrinology Metabolism. 2026;330(2):E143\u201351.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"3","key":"666_CR135","first-page":"201","volume":"1","author":"M Ne\u2019matova","year":"2026","unstructured":"Ne\u2019matova M, et al. Frontiers in Neurological Science: Blood-Based Biomarkers, Artificial Intelligence, and the Gut\u2013Brain Axis as Converging Paradigms in the Diagnosis and Management of Neurological Disorders. Int J Clin Translational Med. 2026;1(3):201\u201310.","journal-title":"Int J Clin Translational Med"},{"issue":"6","key":"666_CR136","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.1007\/s12602-026-10927-w","volume":"18","author":"EB Medeiros","year":"2026","unstructured":"Medeiros EB, et al. Exploring the gut-brain connection: are probiotics the next frontier in Alzheimer\u2019s disease treatment? Probiotics Antimicrob Proteins. 2026;18(6):8209\u201325. https:\/\/doi.org\/10.1007\/s12602-026-10927-w","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"666_CR137","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12035-025-05321-6","volume":"63","author":"HF Hetta","year":"2026","unstructured":"Hetta HF, et al. The gut\u2013brain axis in autism: inflammatory mechanisms, molecular insights, and emerging microbiome-based therapies. Mol Neurobiol. 2026;63(1):211.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"666_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/wasj.2026.464","volume":"8","author":"SS Alkhaldi","year":"2026","unstructured":"Alkhaldi SS, et al. Gut microbiota alterations in autism spectrum disorder: Implications for microbiota-gut-brain axis mechanisms and therapeutic strategies. World Acad Sci J. 2026;8(3):49.","journal-title":"World Acad Sci J"},{"issue":"3","key":"666_CR139","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1473-3099(25)00313-5","volume":"26","author":"A Howard","year":"2026","unstructured":"Howard A, et al. Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery. Lancet Infect Dis. 2026;26(3):e181\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"666_CR140","doi-asserted-by":"publisher","first-page":"e70022","DOI":"10.1111\/jfd.70022","volume":"49","author":"EM Teplitz","year":"2026","unstructured":"Teplitz EM, et al. Disease and antimicrobial resistance surveillance for Nile tilapia pathogens in Lake Victoria, Kenya. J Fish Dis. 2026;49(1):e70022.","journal-title":"J Fish Dis"},{"issue":"2","key":"666_CR141","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11259-025-11043-w","volume":"50","author":"MY Alhassan","year":"2026","unstructured":"Alhassan MY. Veterinary antimicrobial resistance as a climate-sensitive emerging infectious disease: a paradigm shift in one health surveillance. Vet Res Commun. 2026;50(2):98.","journal-title":"Vet Res Commun"},{"issue":"1","key":"666_CR142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.13005\/bpj\/3339","volume":"19","author":"F Alam","year":"2026","unstructured":"Alam F, Ghosh A, Sen A, Dey D, Ghora SS, Guchhait S, Pandey P, Dutta A, Chakraborty P. A comprehensive review on the immune system and immune therapy in liver cancer and colorectal cancer. Biomed Pharmacol J. 2026;19(1):79\u201398. https:\/\/doi.org\/10.13005\/bpj\/3339","journal-title":"Biomed Pharmacol J"},{"issue":"1","key":"666_CR143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21608\/ejmm.2025.383912.1632","volume":"35","author":"ZA Mohammed","year":"2026","unstructured":"MohammedZA, Mohammed M, Ghazi MH, Mohsein OA. The role of herbal extracts in modulating inflammatory cytokines and cancer biomarkers. Egypt J Med Microbiol. 2026;35(1):107\u201315. https:\/\/doi.org\/10.21608\/ejmm.2025.383912.1632","journal-title":"Egypt J Med Microbiol"},{"issue":"1","key":"666_CR144","doi-asserted-by":"publisher","first-page":"e70084","DOI":"10.1111\/sji.70084","volume":"103","author":"AH Banday","year":"2026","unstructured":"Banday AH, et al. From Neoantigen Discovery to Immune-Checkpoint Synergy: Peptide Cancer Vaccines as Precision Tools for Personalised Cancer Therapy. Scand J Immunol. 2026;103(1):e70084.","journal-title":"Scand J Immunol"},{"issue":"3","key":"666_CR145","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt P, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N Engl J Med. 2022;386(3):220\u20139.","journal-title":"N Engl J Med"},{"issue":"7","key":"666_CR146","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103.","journal-title":"Nat Med"},{"issue":"6529","key":"666_CR147","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371(6529):602\u20139.","journal-title":"Science"},{"issue":"7","key":"666_CR148","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25(7):1057\u201363.","journal-title":"Nat Med"},{"issue":"1","key":"666_CR149","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s44371-026-00548-1","volume":"3","author":"IO Abdulsalami","year":"2026","unstructured":"Abdulsalami IO, et al. Dye-sensitized solar cells: a systematic review of progress, challenges, and future perspectives. Discover Chem. 2026;3(1):87.","journal-title":"Discover Chem"},{"issue":"2","key":"666_CR150","first-page":"241","volume":"1","author":"H Tursunaliyeva","year":"2026","unstructured":"Tursunaliyeva H. Contemporary treatment options for diabetes mellitus: current challenges and emerging future perspectives. Int J Clin Translational Med. 2026;1(2):241\u20138.","journal-title":"Int J Clin Translational Med"},{"issue":"3","key":"666_CR151","doi-asserted-by":"publisher","first-page":"e70909","DOI":"10.1111\/ppl.70909","volume":"178","author":"S Bhavana","year":"2026","unstructured":"Bhavana S, et al. The Role of Mathematical Modeling in Plant Abiotic Stress Biology: Current Trends and Future Prospects. Physiol Plant. 2026;178(3):e70909.","journal-title":"Physiol Plant"},{"key":"666_CR152","doi-asserted-by":"crossref","unstructured":"Zhang W, et al. Microbiota-targeted modulation of the gut\u2013kidney axis in diabetic kidney disease: therapeutic advances and future perspectives. Biochem Biophys Res Commun. 2026;153294.","DOI":"10.1016\/j.bbrc.2026.153294"},{"issue":"2","key":"666_CR153","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/microorganisms14020470","volume":"14","author":"RdJ Cano","year":"2026","unstructured":"Cano RdJ, Garc\u00eda Men\u00e9ndez G. Why Clinical Trials of Microbiome-Targeted Interventions Often Fail to Support Health Claims: A Commentary on Probiotics and Translational Design. Microorganisms. 2026;14(2):470.","journal-title":"Microorganisms"},{"issue":"1","key":"666_CR154","doi-asserted-by":"publisher","first-page":"e1013883","DOI":"10.1371\/journal.pcbi.1013883","volume":"22","author":"TT Karagiannis","year":"2026","unstructured":"Karagiannis TT, et al. Integrative analysis across metagenomic taxonomic classifiers: A case study of the gut microbiome in aging and longevity in the Integrative Longevity Omics Study. PLoS Comput Biol. 2026;22(1):e1013883.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"666_CR155","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuron.2025.10.006","volume":"114","author":"KJ Mitchell","year":"2026","unstructured":"Mitchell KJ, Dahly DL, Bishop DV. Conceptual and methodological flaws undermine claims of a link between the gut microbiome and autism. Neuron. 2026;114(2):196\u2013211.","journal-title":"Neuron"},{"issue":"1","key":"666_CR156","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cmet.2025.10.011","volume":"38","author":"M Van Hul","year":"2026","unstructured":"Van Hul M, Cani PD. From microbiome to metabolism: Bridging a two-decade translational gap. Cell Metabol. 2026;38(1):14\u201332.","journal-title":"Cell Metabol"},{"key":"666_CR157","doi-asserted-by":"publisher","first-page":"834622","DOI":"10.3389\/fmicb.2022.834622","volume":"13","author":"R Olmo","year":"2022","unstructured":"Olmo R, et al. Microbiome research as an effective driver of success stories in agrifood systems\u2013a selection of case studies. Front Microbiol. 2022;13:834622.","journal-title":"Front Microbiol"},{"issue":"4","key":"666_CR158","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41591-025-03615-9","volume":"31","author":"JA Gilbert","year":"2025","unstructured":"Gilbert JA, et al. Clinical translation of microbiome research. Nat Med. 2025;31(4):1099\u2013113.","journal-title":"Nat Med"},{"issue":"1","key":"666_CR159","doi-asserted-by":"publisher","first-page":"113133","DOI":"10.4253\/wjge.v18.i1.113133","volume":"18","author":"PK Uppala","year":"2026","unstructured":"Uppala PK, Karanam SK, Maddi R. Science of fecal microbiota transplant: From history to cutting-edge clinical practice. World J Gastrointest Endoscopy. 2026;18(1):113133.","journal-title":"World J Gastrointest Endoscopy"},{"issue":"11","key":"666_CR160","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41564-022-01173-1","volume":"7","author":"RS Peixoto","year":"2022","unstructured":"Peixoto RS, et al. Harnessing the microbiome to prevent global biodiversity loss. Nat Microbiol. 2022;7(11):1726\u201335.","journal-title":"Nat Microbiol"},{"key":"666_CR161","unstructured":"Davis W. Super gut: a four-week plan to reprogram your microbiome, restore health, and lose weight. Hachette UK. 2022."},{"issue":"166","key":"666_CR162","doi-asserted-by":"publisher","first-page":"220121","DOI":"10.1183\/16000617.0121-2022","volume":"31","author":"G von Mitropoulou","year":"2022","unstructured":"Mitropoulou G, Koutsokera A, Csajka C, Blanchon S, Sauty A, Brunet JF, von Garnier C, Resch G, Guery B. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur Respir Rev. 2022;31(166):220121. https:\/\/doi.org\/10.1183\/16000617.0121-2022","journal-title":"Eur Respir Rev"},{"issue":"5","key":"666_CR163","doi-asserted-by":"publisher","first-page":"001405","DOI":"10.1099\/mgen.0.001405","volume":"11","author":"A Metris","year":"2025","unstructured":"Metris A, et al. Assessing the safety of microbiome perturbations. Microb genomics. 2025;11(5):001405.","journal-title":"Microb genomics"},{"key":"666_CR164","doi-asserted-by":"publisher","first-page":"1675458","DOI":"10.3389\/fmed.2025.1675458","volume":"12","author":"S Alobaidi","year":"2025","unstructured":"Alobaidi S. The gut\u2013kidney axis in chronic kidney disease: mechanisms, microbial metabolites, and microbiome-targeted therapeutics. Front Med. 2025;12:1675458.","journal-title":"Front Med"},{"issue":"5","key":"666_CR165","doi-asserted-by":"publisher","first-page":"e2501002","DOI":"10.71150\/jm.2501002","volume":"63","author":"MS Hossain","year":"2025","unstructured":"Hossain MS, et al. Microbiome therapeutic PMC72 through reverse translational research in gout. J Microbiol. 2025;63(5):e2501002.","journal-title":"J Microbiol"},{"key":"666_CR166","doi-asserted-by":"publisher","first-page":"1727736","DOI":"10.3389\/fmicb.2026.1727736","volume":"17","author":"Y Liu","year":"2026","unstructured":"Liu Y, et al. Microbial dysbiosis in cholangiocarcinoma. Front Microbiol. 2026;17:1727736.","journal-title":"Front Microbiol"},{"key":"666_CR167","doi-asserted-by":"publisher","first-page":"1815611","DOI":"10.3389\/frabi.2026.1815611","volume":"5","author":"AC Ngene","year":"2026","unstructured":"Ngene AC, et al. Translational barriers to phage endolysin deployment for antimicrobial resistance control in Africa. Front Antibiot. 2026;5:1815611.","journal-title":"Front Antibiot"},{"issue":"21","key":"666_CR168","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.3390\/foods14213654","volume":"14","author":"T Alhasyani","year":"2025","unstructured":"Alhasyani T, et al. Harnessing Edible Insect Bioactives for Gut Health: A Comprehensive Review on Chitin-Derived Prebiotics and Peptidomic Insights from the Black Soldier Fly. Foods. 2025;14(21):3654.","journal-title":"Foods"},{"issue":"3","key":"666_CR169","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/nu14030480","volume":"14","author":"JM van Dorst","year":"2022","unstructured":"van Dorst JM, Tam RY, Ooi CY. What do we know about the microbiome in cystic fibrosis? Is there a role for probiotics and prebiotics? Nutrients. 2022;14(3):480.","journal-title":"Nutrients"},{"key":"666_CR170","doi-asserted-by":"crossref","unstructured":"Gudnadottir U, et al. Prenatal and early childhood exposure to antibiotics or gastric acid inhibitors and increased risk of epilepsy: a nationwide population-based study. Clin Pharmacol Ther. 2025;118(1):206\u201317.","DOI":"10.1002\/cpt.3679"},{"issue":"23","key":"666_CR171","doi-asserted-by":"publisher","first-page":"12613","DOI":"10.3390\/ijms252312613","volume":"25","author":"C Toader","year":"2024","unstructured":"Toader C, et al. Decoding neurodegeneration: a review of molecular mechanisms and therapeutic advances in Alzheimer\u2019s, Parkinson\u2019s, and ALS. Int J Mol Sci. 2024;25(23):12613.","journal-title":"Int J Mol Sci"},{"key":"666_CR172","doi-asserted-by":"crossref","unstructured":"Gao Y, Li D, Liu Y-X. Microbiome research outlook: past, present, and future. Oxford University Press US. 2023;709\u201312.","DOI":"10.1093\/procel\/pwad031"},{"key":"666_CR173","doi-asserted-by":"crossref","unstructured":"Sood A et al. Future directions in gut microbiota research: prospects and challenges. Gut Microbiota. 2025;221\u2013244.","DOI":"10.1201\/9781003596844-10"},{"key":"666_CR174","first-page":"100002","volume":"1","author":"AM Fahmy","year":"2024","unstructured":"Fahmy AM. Microbiome and Human Health: Recent Insights and Future Directions. Public Health. 2024;1:100002.","journal-title":"Public Health"},{"issue":"1","key":"666_CR175","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/0113892037357900250401020207","volume":"27","author":"J Dwivedi","year":"2026","unstructured":"Dwivedi J, et al. Messenger RNA Nanomedicine: Innovations and Future Directions. Curr Protein Pept Sci. 2026;27(1):66\u201391.","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"666_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43657-023-00131-z","volume":"5","author":"H Wu","year":"2025","unstructured":"Wu H, et al. Human gut microbiome researches over the last decade: current challenges and future directions. Phenomics. 2025;5(1):1\u20137.","journal-title":"Phenomics"},{"issue":"2","key":"666_CR177","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41588-021-00983-z","volume":"54","author":"S Sanna","year":"2022","unstructured":"Sanna S, et al. Challenges and future directions for studying effects of host genetics on the gut microbiome. Nat Genet. 2022;54(2):100\u20136.","journal-title":"Nat Genet"},{"issue":"9","key":"666_CR178","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","volume":"28","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K. Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions. Mol Psychiatry. 2023;28(9):3625\u201337.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"666_CR179","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/cancers15072101","volume":"15","author":"DE Kiousi","year":"2023","unstructured":"Kiousi DE, et al. The role of the gut microbiome in cancer immunotherapy: current knowledge and future directions. Cancers. 2023;15(7):2101.","journal-title":"Cancers"},{"key":"666_CR180","doi-asserted-by":"publisher","first-page":"86","DOI":"10.30574\/wjbphs.2024.19.1.0396","volume":"19","author":"N Mehta","year":"2024","unstructured":"Mehta N. Microbiome and mind: Current insights and future directions in gut\u2013brain research. World J Biol Pharm Health Sci. 2024;19:86\u201394.","journal-title":"World J Biol Pharm Health Sci"},{"key":"666_CR181","doi-asserted-by":"publisher","first-page":"1377012","DOI":"10.3389\/fcimb.2024.1377012","volume":"14","author":"S Filardo","year":"2024","unstructured":"Filardo S, Pietro MD, Sessa R. Current progresses and challenges for microbiome research in human health: a perspective. Front Cell Infect Microbiol. 2024;14:1377012.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"666_CR182","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-022-00381-5","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang Y. Intratumor microbiome in cancer progression: current developments, challenges and future trends. Biomark Res. 2022;10(1):37.","journal-title":"Biomark Res"},{"key":"666_CR183","doi-asserted-by":"publisher","first-page":"e2412001","DOI":"10.4014\/jmb.2412.12001","volume":"35","author":"S-Y Yang","year":"2025","unstructured":"Yang S-Y, et al. Advancing gut microbiome research: the shift from metagenomics to multi-omics and future perspectives. J Microbiol Biotechnol. 2025;35:e2412001.","journal-title":"J Microbiol Biotechnol"},{"issue":"6","key":"666_CR184","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/nph.18016","volume":"234","author":"P Trivedi","year":"2022","unstructured":"Trivedi P, et al. Plant\u2013microbiome interactions under a changing world: responses, consequences and perspectives. New Phytol. 2022;234(6):1951\u20139.","journal-title":"New Phytol"},{"issue":"2","key":"666_CR185","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/1541-4337.13103","volume":"22","author":"I Ferrocino","year":"2023","unstructured":"Ferrocino I, et al. The need for an integrated multi-OMICs approach in microbiome science in the food system. Compr Rev Food Sci Food Saf. 2023;22(2):1082\u2013103.","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"3","key":"666_CR186","doi-asserted-by":"publisher","first-page":"102681","DOI":"10.1016\/j.xcrm.2026.102681","volume":"7","author":"L Qiao","year":"2026","unstructured":"Qiao L, Wang Z, Tang S, Tian J, Ye H, Cai F. Engineering smart bacteria for the next generation. Cell Rep Med. 2026;7(3):102681. https:\/\/doi.org\/10.1016\/j.xcrm.2026.102681","journal-title":"Cell Rep Med"},{"issue":"4","key":"666_CR187","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/07388551.2023.2208285","volume":"44","author":"S Ma","year":"2024","unstructured":"Ma S, et al. Bacterial genome reduction for optimal chassis of synthetic biology: a review. Crit Rev Biotechnol. 2024;44(4):660\u201373.","journal-title":"Crit Rev Biotechnol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00666-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00666-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00666-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:03:19Z","timestamp":1791183799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00666-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":187,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00666-2","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"91"}}